1. |
Siegel R, DeSantis C, Virgo K,et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin, 2012, 62(4): 220-241.
|
2. |
Spira A, Ettinger DS. Multidisciplinary management of lung cancer. N Engl J Med, 2004, 350(4): 379-392.
|
3. |
Katoh M. Human FOX gene family (Review). Int J Oncol, 2004, 25(5): 1495-1500.
|
4. |
Wonsey DR, Follettie MT. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe. Cancer Res, 2005, 65(12): 5181-5189.
|
5. |
Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem, 2007, 388(12): 1257-1274.
|
6. |
Kim IM, Ackerson T, Ramakrishna S,et al. The forkhead box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res, 2006, 66(4): 2153-2161.
|
7. |
Yang DK, Son CH, Lee SK,et al. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance. Hum Pathol, 2009, 40(4): 464-470.
|
8. |
刘怡茜, 郭人花, 刘连科, 等. 叉头框转录因子 M1 在非小细胞癌中的表达及其与患者病理特征和生存关系. 中华肿瘤杂志, 2011, 33(6): 426-430.
|
9. |
Xu N, Wu SD, Wang H,et a1. Involvement of foxm1 in non-small cell lung cancer recurrence. Asian Pac J Cancer Prev, 2012, 13(9): 4739-4743.
|
10. |
Wang Y, Wen L, Zhao SH,et al. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer, 2013, 79(2): 173-179.
|
11. |
Xu N, Jia D, Chen W,et al. FoxM1 Is Associated with Poor Prognosis of Non-Small Cell Lung Cancer Patients through Promoting Tumor Metastasis. PLoS One, 2013, 8(3): e59412.
|
12. |
陈芸, 梁鸿镖, 吴琼雅, 等. 叉头框转录因子 M1 在非小细胞肺癌中的表达及临床意义. 解放军医药杂志, 2013, 25(5): 48-52.
|
13. |
Chen PM, Cheng YW, Wang YC,et al. Up-regulation of FOXM1 by E6 oncoprotein through the MZF1/NKX2-1 axis is required for human papillomavirus-associated tumorigenesis. Neoplasia (New York, NY), 2014, 16(11): 961-971.
|
14. |
Kong FF, Qu ZQ, Yuan HH,et al. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Oncol Rep, 2014, 31(6): 2660-2668.
|
15. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
16. |
江峰, 吕赛平, 黄秀珍, 等. 非小细胞肺癌组织表达 FOXM1 与患者临床特征及术后辅助化疗疗效的关系研究. 中国医学创新, 2014, 30: 1-3.
|
17. |
Li X, Qiu W, Liu B,et al. Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel. J Transl Med, 2013, 11: 204.
|
18. |
Xia JT, Wang H, Liang LJ,et al. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma. Pancreas, 2012, 41(4): 629-635.
|
19. |
Chu XY, Zhu ZM, Chen LB,et al. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochem, 2012, 114(8): 755-762.
|
20. |
Wen N, Wang Y, Wen L,et al. Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer. J Transl Med, 2014, 12: 134.
|
21. |
He SY, Shen HW, Xu L,et al. FOXM1 promotes tumor cell invasion and correlates with poor prognosis in early-stage cervical cancer. Gynecol Oncol, 2012, 127(3): 601-610.
|
22. |
Park HJ, Gusarova G, Wang Z,et al. Deregulation of FoxM1b leads to tumour metastasis. EMBO Mol Med, 2011, 3(1): 21-34.
|
23. |
Wang HX, Teh MT, Ji YM,et al. EPS8 upregulates FOXM1 expression, enhancing cell growth and motility. Carcinogenesis, 2010, 31(6): 1132-1141.
|
24. |
Wei P, Zhang N, Wang Y,et al. FOXM1 promotes lung adenocarcinoma invasion and metastasis by upregulating SNAIL. Int J Biol Sci, 2015, 11(2): 186-198.
|
25. |
Dai J, Yang L, Wang J,et al. Prognostic value of FOXM1 in patients with malignant solid tumor: a meta-analysis and systemativ review. Dis Markers, 2015, 2015: 352478.
|
26. |
Laoukili J, Kooistra MRH, Bras A,et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol, 2005, 7(2): 126-134.
|
27. |
Wang IC, Chen YJ, Hughes D,et al. Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol, 2005, 25(24): 10875-10894.
|
28. |
Balli D, Ren X, Chou FS,et al. Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation. Oncogene, 2012, 31(34): 3875-3888.
|
29. |
Koo CY, Muir KW, Lam EWF. FOXM1: From cancer initiation to progression and treatment. Biochim Biophys Acta, 2012, 1819(1): 28-37.
|
30. |
Myatt SS, Lam EWF. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer, 2007, 7(11): 847-859.
|
31. |
Wang IC, Meliton L, Ren X,et al. Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis. Plos One, 2009, 4(8): e6609.
|
32. |
Balli D, Zhang YF, Snyder J,et al. Endothelial cell-specific deletion of transcription factor FoxM1 increases urethane-induced lung carcinogenesis. Cancer Res, 2011, 71(1): 40-50.
|
33. |
Wang IC, Meliton L, Tretiakova M,et al. Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors. Oncogene, 2008, 27(30): 4137-4149.
|
34. |
Li Q, Zhang N, Jia ZL,et al. Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression. Cancer Res, 2009, 69(8): 3501-3509.
|
35. |
Zhang YJ, Zhang N, Dai BB,et al. FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res, 2008, 68(21): 8733-8742.
|
36. |
Liu Y, Chen X, Gu Y,et al. FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK/mitochondrial pathway. Neoplasma, 2015, 62(1): 61-71.
|